Immune Response Following Seasonal Influenza Vaccination
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Influenza
Related studies linked through entity extraction aliases.
Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2017-2018 Season
- Status
- COMPLETED
- Phase
- PHASE4
Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age
- Status
- COMPLETED
- Phase
- PHASE4
High Dose vs. Standard Influenza Vaccine in Adult SOT
- Status
- COMPLETED
- Phase
- PHASE3
Assessment of Viral Shedding in Children Previously in Receipt of Multiple Doses of Live Attenuated Influenza Vaccine (LAIV) Compared to Influenza Vaccine-naïve Controls
- Status
- COMPLETED
- Phase
- PHASE4
Live Attenuated Influenza Vaccine (LAIV) Versus Trivalent Inactivated Influenza Vaccine in Healthy Adults 18-49 Years
- Status
- COMPLETED
- Phase
- PHASE4
Genetic and Environmental Factors in the Response to Influenza Vaccination
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, and Immunogenicity of VAL-506440 in Healthy Adult Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Comparison of Three Licensed Influenza Vaccines
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab)
- Status
- COMPLETED
- Phase
- N/A
Two Doses of Multimeric-001 (M-001) Followed by Influenza Vaccine
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Performance of the Diassess Influenza A and B Test
- Status
- COMPLETED
- Phase
- NA
Adaptive Immune Responses and Repertoire in Influenza Vaccination and Infection (SLVP031)
- Status
- TERMINATED
- Phase
- PHASE4
Innate and Acquired Immunity to Influenza Infection and Immunization (SLVP029)
- Status
- COMPLETED
- Phase
- PHASE4
Tissue-specific Responses to Influenza Immunization and Their Relation to Blood Biomarkers (SLVP032)
- Status
- TERMINATED
- Phase
- PHASE4
Protective Mechanisms Against a Pandemic Respiratory Virus (SLVP024)
- Status
- COMPLETED
- Phase
- PHASE4
The Human Mucosal Immune Responses to Influenza Virus (SLVP026)
- Status
- COMPLETED
- Phase
- PHASE4
T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 5, 2013
- Status
- COMPLETED
- Phase
- PHASE4
T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 4, 2012
- Status
- COMPLETED
- Phase
- PHASE4
T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 3, 2011
- Status
- COMPLETED
- Phase
- PHASE4